Alydia Health: "The Jada System treats postpartum hemorrhage and abnormal postpartum uterine bleeding using low-level vacuum to induce the normal and necessary postpartum uterine contraction that should naturally occur after childbirth."
This week Women's Health Innovation Summit announced their Women's Health Innovation Showcase Winners. Reason enough for us to talke a closer look at the selected companies today!
OCON Healthcare develops innovative and safe medical solutions that are inspired by women’s bodies and anatomy, to better the lives of women everywhere. OCON’s first product, the IUB™ Ballerine®, is a CE approved copper-based hormone-free intrauterine contraceptive
PregnanTech has developed LIONESS, a novel, non-surgical and safe solution for the prevention of preterm birth.
Emme is a healthcare technology company with a mission to put women’s health in women’s hands, starting with birth control. Their first product, the Emme Smart Case and app, is an integrated technology-enabled solution designed to safeguard the birth control experience and help reduce the rate of missed pills.
Babyscripts is a new model for prenatal and postpartum care, that is transforming the way expectant mothers use technology to work with their healthcare providers.
Nuvo is an emerging leader in maternal-fetal connected health, passionate about creating technology that radically transforms the experience of pregnancy for expectant parents and healthcare providers.
PulseNmore is an emerging leader in connected at-home ultrasound, delivering convenience and efficiency beyond traditional in-facility imaging.
Nest Collaborative is improving maternal-child health by expanding access to payer-reimbursed telelactation support.
Alydia Health is a medical device company working toward a solution for postpartum bleeding and hemorrhage (PPH), the number one cause of maternal death.
Raydiant Oximetry is developing a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood.
MOMM Diagnostics specializes in the development of an in-vitro diagnostic test for the early diagnosis of preeclampsia.
